NCT02626559View on ClinicalTrials.gov

Serum Bupivacaine Concentration Levels After Injection of Liposomal Bupivacaine Into the Knee

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

November 30, 2016

Study Completion Date

November 30, 2016

Conditions
Anesthesia, Local
Interventions
DRUG

liposomal bupivacaine/plain bupivacaine peri-articular injection

Injection of a mixture of liposomal and plain bupivacaine around the knee during total knee arthroplasty.

Trial Locations (1)

84132

Uutah, Salt Lake City

All Listed Sponsors
lead

University of Utah

OTHER

NCT02626559 - Serum Bupivacaine Concentration Levels After Injection of Liposomal Bupivacaine Into the Knee | Biotech Hunter | Biotech Hunter